B. Lynne Parshall, Director at IONIS PHARMACEUTICALS INC (IONS), sold 10,000 shares at $45.13 ($451K) on 2023-09-26, disclosed to the SEC on 2023-09-28.
Scheduled sale ($451k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| IONS | SELL | 2026-04-17 | $381K | — | Filing → |
| CYTK | SELL | 2026-03-02 | $306K | — | Filing → |
| IONS | SELL | 2026-02-13 | $414K | — | Filing → |